Business ❯ Pharmaceutical Industry

Corporate Acquisitions

Mergers and Acquisitions Novartis Sanofi Alliance Pharma Oncology Companies Generic Drug Market Johnson & Johnson Biotech Companies

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

The cash offer centers on tovorafenib for pediatric low‑grade glioma to advance Servier’s precision oncology strategy.

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

Novartis Ianalumab Meets Efficacy and Safety Goals in Phase 3 Sjögren’s Trials